Crossmark

First pan-specific vNAR against human TGF-β as a potential therapeutic application: in silico modeling assessment

Crossref DOI link: https://doi.org/10.1038/s41598-023-30623-x

Published Online: 2023-03-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Burciaga-Flores, Mirna https://orcid.org/0000-0002-9095-3563
Márquez-Aguirre, Ana Laura https://orcid.org/0000-0001-5662-9076
Dueñas, Salvador https://orcid.org/0000-0002-0818-820X
Gasperin-Bulbarela, Jahaziel https://orcid.org/0000-0001-6591-3968
Licea-Navarro, Alexei F. https://orcid.org/0000-0003-4022-7405
Camacho-Villegas, Tanya A. https://orcid.org/0000-0002-0540-0287
License Information

Text and Data Mining valid from 2023-03-03

Version of Record valid from 2023-03-03
More Information

Article History

Received: 14 December 2022

Accepted: 27 February 2023

First Online: 3 March 2023

Competing interests

: The authors declare no competing interests.